Emergency Action is Necessary to Provide Payment for Pharmacist Prescribing of Paxlovid

APhA needs your assistance to ensure you can effectively care for you patients. Reach out to your Member of Congress and Senators and ask them to take immediate action to provide adequate, appropriate, and fair payment for pharmacist consultations and services for prescribing Paxlovid.

Act now  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Community Pharmacy Workplace Summit

APhA is committed to facilitating meaningful dialogue between pharmacy management, pharmacy team members, and other stakeholders that result in improved workplaces, well-being, and ability to meet ethical obligations to patient safety.

Learn more  

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  


Latest from APhA

View CEO Blog

Ilisa Bernstein's Letter to the FDA Regarding Pharmacists Prescribing Oral COVID-19 Treatments

A letter from Interim CEO Ilisa Bernstein, PharmD, JD, FAPhA, to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA), on the importance of pharmacists being allowed to prescribe oral COVID-19 treatments.


Breaking: APhA issues statement in response to Supreme Court’s Dobbs v Jackson decision

(July 25, 2022) WASHINGTON, DC— For the past month, the American Pharmacists Association (APhA) has been advocating for patients and pharmacists regarding the Dobbs v Jackson Supreme Court decision. This work has included engaging with members


Pharmacy news

View all news

Researchers say heart disease will surge in next decade

A new study in The Journal of the American College of Cardiology predicts that millions more Americans will develop CVD over the next few decades.

Study finds many older adults not getting medication reviews

Many older adults are not receiving comprehensive medication reviews (CMR), according to a new report from University of Michigan researchers.